10 MAY

Creative Solutions for US Biotech Clinical Trial



A US-based Biotech company was seeking a CRO who could successfully recruit a large number of elderly research participants in New Zealand. A challenge that was not only squeezed into a three-month seasonal recruitment window but was also met with issues so unique, there were no established protocols.

PharmaSols history of flexible, rapid, and creative solutions meant we were the ideal CRO partner to take on their unique problems.

Our centralised and efficient ethics and regulatory bodies in New Zealand enabled us to swiftly obtain the necessary approvals prior to the first site initiation visit (SIV). These short start-up timelines gave us the competitive advantage in recruiting significantly more participants compared to our global CRO partner – utilising the same number of trial sites.


There were a number of challenges while supporting this study:

  • Tight timelines and the challenges of getting ethics and regulatory approval quickly
  • Recruiting a large number of research participants in a short period
  • Engaging an elderly population to participate in a research trial
  • Technology challenges in working with an elderly population while collecting daily diary information via iPads
  • Issues with iPad connectivity
  • Overseas central laboratory’s online results portal going down during the study

Establishing sites and CRAs

The driving force behind our success is our dedicated people-focused approach and our flexibility in handling unusual challenges.

Straight away, we established an experienced team and used a higher ratio of CRAs to support the selected trial sites.

Along with their expertise, we selected CRAs located near the trial sites – allowing them to respond rapidly to any problems and assist with high recruitment and peaks in monitoring activities.

Having fostered strong relationships with the site staff over many years, our CRAs could support them through any issues that arose with technology, working with an elderly population, and keeping them motivated to achieve the trial milestones.

Resolving IT problems

As the study required iPads for the elderly trial participants to record their data on, our team assisted with the receipt from the US and delivery of them to the trial sites around the country.

Unfortunately, in addition to complexities in working with an elderly population using new technology, the iPads also had connectivity issues, which meant our sponsor was losing critical daily data.

With our well-established history of innovative problem solving, our team helped facilitate urgent meetings with the sponsor and technical support teams, resulting in IT experts flying in from overseas that the PharmaSols team hosted.

After determining that the iPads needed new SIM cards, we facilitated the IT experts’ travel around the country to assess the devices and help replace SIM cards.

This was a highly unique challenge and one that the PharmaSols team was readily able to assist with.

Finding a bespoke solution

Our sponsor was struck with yet another stress when a Central European laboratory processing the trial samples became the victim of a cyberattack. This prevented our sites from accessing the lab results data they needed to determine which of the participants could proceed forward in the trial.

The trial site staff became inundated with calls from confused participants, unsure if they were allowed to continue in the trial. The PharmaSols team received numerous daily calls and emails from trial site staff requesting critical laboratory results.

PharmaSols’ agility once again became a defining solution for this trial. By working closely with the lab, we manually determined which participants' lab results could be prioritised each day. We provided the sites with daily updates and kept the trial on track.


By obtaining the first SIV in less than 35 days and recruiting almost twice as many patients as our global CRO partner, we easily met the client’s deadline.

When faced with critical data not transmitting from patient iPads, PharmaSols facilitated urgent meetings with the technology provider to resolve the issue quickly and keep the trial going.

Our team also tracked data manually when the overseas lab’s systems went down and briefed our sites regularly, so they knew which patients could stay in the trial.

The end result was a successful clinical trial and a very happy sponsor.

“We have chosen to do many of our clinical trials in Australia and New Zealand because of the very high quality of investigators, site staff, and clinical research organisations (PharmaSols). They have a wonderful ‘can-do’ attitude which is really important for getting clinical trials done on time and on budget.”

US Biotech Company

Case Studies

Rapid Study Start-up for Phase 1 Dermatology Study in Australia for a UK Biotech Company

PharmaSols was contracted by a small UK-based biotech company to conduct a Phase 1 dermatology clinical trial in Australia. The sponsor was looking to get the study started within a short period of time to achieve the ‘first patient in’ milestone for their investors.

Read more
Successful Phase 2 Obesity Clinical Trial in the ANZ Region for a US Biotech Company

PharmaSols was contracted by a small US-based biotech company to conduct a Phase 2 obesity clinical trial. The study required the recruitment of 325 eligible participants across 16 sites in Australia and New Zealand.

Read more
PharmaSols achieve rapid start-up for complex 1b oncology study

A US-based biopharmaceutical company was looking to run a Complex 1b Oncology study. The study needed to be handled by a CRO that could manage tight timeframes, and it was imperative that it be carried out without costly interruptions.

Read more
Creating Solutions to Deliver Rapid & High-Quality Clinical Trials

Our team have needed to respond quickly to challenges supporting different studies and the experience of our team has enabled us to create rapid solutions for our global sponsors.

Read more
Expedited Timeframes and Exceeded Targets for COVID-19 Diagnostic Trial

PharmaSols were engaged by an organisation looking to run a clinical trial for a COVID-19 diagnostic test. It was imperative that this study be carried out without costly interruptions and needed to be handled by a CRO that could manage tight timeframes.

Read more
Patient Recruitment Targets Exceeded for COVID-19 Vaccine Trial

Due to PharmaSols unique location and history of successful rapid start-ups, we were engaged by a European specialty vaccine company running a COVID-19 vaccine study. This study needed to be conducted without interruptions caused by the virus itself and with a CRO that could handle tight recruitment timeframes.

Read more
Expedited Timelines and Recruitment Success for COVID-19 Vaccine Trial

While the pandemic has slowed down most of the globe, it has increased the demand for rapid solutions within the pharmaceutical industry, with an urgent need to find a vaccine and COVID-19 related treatments and vaccines. Running clinical trials for potential solutions is a vital element in this process.

Read more
Exceeding Site Identification Targets Across Three Recent Clinical Trial Studies

Site identification is the first and most critical deliverable from a CRO. Without an appropriate site, there is no patient recruitment, and without patients, there is no study.

Read more
High Recruitment: Twice as many patients as global CRO

Faced with a challenging recruitment process, needing to recruit a large number of elderly participants within a tight three-month seasonal recruitment window, a US-based Biotech Company appointed PharmaSols as the NZ CRO for this phase three respiratory clinical trial.

Read more
Rapid start-up: First SIV in less than 35 days

Having previously worked with PharmaSols over a number of trials, the US sponsor knew that the PharmaSols team could deliver on both tight start-up timelines and high recruitment targets. PharmaSols proven record of flexible, rapid, and creative solutions meant we were the ideal CRO partner.

Read more
Rapid Start-up and Tight FPI Timeline for US Biotech Clinical Trial

After a sudden decision to expedite their study timelines, a US Biotech company approached PharmaSols in need of a CRO who could successfully achieve a quality rapid start-up within a tight timeline.

Read more
Quick Feasibility for Rare Genetic Trial

A US Biotech company reached out to PharmaSols, to investigate the feasibility of running a trial in New Zealand on participants' stored tissue samples, where consent had been given for further research to identify a rare genetic marker.

Read more